Csenge Advisory Group’s Encompass Health EHC Stock Holding History

Csenge Advisory Group’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-58	Closed	-$3K	–	549
2018 Q3	$3K	Buy	+58	New	+$3.53K	﹤0.01%	684

Other funds holding EHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Csenge Advisory Group's EHC Position: Q4 2018 in Review

Csenge Advisory Group sold out of Encompass Health (EHC) in Q4 2018, closing a stake of 58 shares — an estimated $3K sold.

Csenge Advisory Group first reported a position in EHC in Q3 2018 and held it in 1 quarter. The position peaked at $3K in Q3 2018. 447 funds tracked by Wall St. Rank hold EHC as of Q4 2018.

Csenge Advisory Group reported no remaining Encompass Health position as of Q4 2018 after selling out during the quarter.
Csenge Advisory Group sold 58 Encompass Health shares in Q4 2018, an estimated $3K.
Csenge Advisory Group first reported a position in Encompass Health in Q3 2018 and held it in 1 quarter.
Csenge Advisory Group's Encompass Health position peaked at $3K in Q3 2018.
447 funds tracked by Wall St. Rank held Encompass Health as of Q4 2018.

Based on Csenge Advisory Group's 13F filing for Q4 2018, filed 7 Feb 2019.